What Is Fragility? Frailty Syndrome and Fracture Risk

Fragility, in a medical context, refers to a state of increased vulnerability where the body’s reserves have declined to the point that even minor stresses (a fall, a mild infection, a change in medication) can trigger serious health consequences. It is most commonly discussed in two overlapping ways: physical frailty, a recognized syndrome affecting roughly 12% of adults over 65 worldwide, and bone fragility, a weakening of skeletal tissue that raises fracture risk. Both are distinct from normal aging, and both are at least partially reversible with the right interventions.

Frailty as a Medical Syndrome

Frailty is not simply “getting old.” While aging gradually reduces the body’s ability to adapt to stress, frailty represents a sharper, more specific decline centered on energy metabolism and the neuromuscular system. A person can be 85 and not frail, or 65 and clearly frail. The key distinction is that frail individuals show measurable changes in physical performance and biological markers that go well beyond what’s expected for their age.

The most widely used definition comes from a model built around five physical criteria: unintentional weight loss, self-reported exhaustion, low physical activity, slow walking speed, and weak grip strength. Meeting three or more of these criteria qualifies as frail. One or two puts you in the “pre-frail” category. Zero means robust. This framework gives clinicians a simple, reproducible way to identify who is at risk.

A second approach counts accumulated health deficits rather than checking specific physical markers. Under this model, a clinician tallies everything from symptoms and diseases to lab abnormalities, then divides the number of deficits present by the total number considered. Someone with 10 deficits out of 40 possible would score 0.25. The higher the ratio, the more frail the person. This method tends to capture a broader picture of overall health decline.

How Common Is Frailty?

A systematic review covering 62 countries and more than 1.7 million participants found that about 12% of older adults meet the physical criteria for frailty, while 46% are pre-frail. When the deficit accumulation model is used instead, the numbers jump to 24% frail and 49% pre-frail, since that approach casts a wider net. Frailty is more common in women: 15% of females meet the physical criteria compared to 11% of males. Prevalence climbs steadily with age.

What Happens Inside the Body

Several biological processes converge to produce frailty. The most visible is the loss of muscle mass and function, sometimes called sarcopenia. As people age, the body gradually shifts from building new proteins to breaking them down, and the capacity to repair muscle damage shrinks. Hormones that support muscle, including testosterone, estrogen, and DHEA, decline with age and accelerate this process. At the same time, a protein called myostatin, which actively inhibits muscle growth, tends to increase.

Chronic low-grade inflammation plays a central role. Aging immune systems produce elevated levels of inflammatory molecules. This persistent, smoldering inflammation, sometimes called “inflammaging,” is inversely related to muscle mass and strength. People with higher levels of these inflammatory markers are more likely to develop mobility limitations, independent of heart disease or other serious illnesses.

Oxidative stress compounds the damage. Reactive oxygen species accumulate with age and damage cellular proteins, contributing to tissue decline. Markers of this oxidative damage are independently associated with weaker grip strength. Insulin resistance and poor blood sugar control also correlate with muscle loss, creating a vicious cycle where metabolic dysfunction feeds physical decline and vice versa.

Frailty’s Impact on Health Outcomes

Frailty is not just a label. It carries real, measurable risks. Data from a large U.S. national health survey showed that frail individuals had 2.8 times the risk of death compared to robust individuals of similar age, even after adjusting for diabetes, heart failure, cancer, and other chronic conditions. Pre-frail people had 1.6 times the risk. For cardiovascular death specifically, the numbers were even starker: 3.4 times the risk for frail individuals and 1.8 times for pre-frail.

These elevated risks make frailty assessment valuable before surgeries, cancer treatments, or any major medical decision. Someone who appears healthy on paper but scores as frail may need a different treatment approach than their age alone would suggest.

The Clinical Frailty Scale

In clinical settings, a nine-point scale provides a quick snapshot of someone’s frailty level. At the low end, a score of 1 describes people who are robust, energetic, and exercise regularly. A score of 3 means someone whose health problems are well controlled but who isn’t active beyond routine walking. At a score of 5 (mild frailty), people typically need help with tasks like managing finances, shopping, preparing meals, or walking outside alone. By score 7 (severe frailty), a person is completely dependent on others for personal care but remains relatively stable. Scores of 8 and 9 describe people approaching end of life.

This scale is useful because it captures the lived experience of frailty rather than relying on lab tests or grip strength measurements. It helps families and clinicians quickly align on where someone stands.

Bone Fragility and Fracture Risk

Bone fragility is a related but distinct concept. It refers specifically to weakened bone tissue that breaks under forces that wouldn’t fracture healthy bone, such as a fall from standing height. The World Health Organization defines osteoporosis, the primary cause of bone fragility, using bone density scans. A T-score of negative 2.5 or lower at the hip qualifies as osteoporosis, while scores between negative 1 and negative 2.5 indicate osteopenia, a milder form of bone loss. When someone has both a T-score at or below negative 2.5 and has already sustained a fragility fracture, the diagnosis is severe osteoporosis.

One important and perhaps surprising finding: most people who suffer fragility fractures do not actually have T-scores below negative 2.5. This means bone density alone doesn’t capture the full picture of fracture risk. Factors like bone quality, fall risk, muscle weakness, and overall frailty all contribute.

Slowing and Reversing Fragility

The most encouraging aspect of frailty is that it responds to intervention, particularly in the pre-frail and mildly frail stages. Two strategies have the strongest evidence behind them: resistance training and increased protein intake.

Strength training is the single most effective tool. A randomized trial in frail older adults found that resistance exercises performed three times per week for 12 weeks produced meaningful improvements in muscle strength, the ability to stand from a chair, and walking endurance. Higher-intensity training produced the largest gains, but even low-to-moderate intensity was safe, effective, and well-tolerated. The key improvements in walking speed and strength directly target the two most common deficits on the frailty spectrum.

Protein intake matters more than many people realize. The standard recommended daily allowance of 0.8 grams of protein per kilogram of body weight appears insufficient for older adults trying to preserve muscle. Expert consensus statements now suggest 1.0 to 1.5 grams per kilogram per day to prevent or slow age-related muscle loss. For a 150-pound person, that translates to roughly 68 to 102 grams of protein daily, a significant increase over what many older adults typically eat. Multiple studies show an inverse relationship between protein intake and frailty prevalence: people who eat more protein are less likely to become frail.

Combining these two approaches, regular resistance exercise with adequate protein, addresses the core biology of frailty from both sides: stimulating muscle growth while providing the raw materials needed to build and repair tissue. Neither works as well alone as they do together.